CNY 63.18
(-0.44%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 166.97 Million | 31.04 Million | 10.96 Million | 29.7 Million | 19.43 Million | 11.79 Million |
Net Income | 200.71 Million | 141.15 Million | 120.61 Million | 68.21 Million | 61.77 Million | 55.82 Million |
Depreciation & Amortization | 24.14 Million | 23.64 Million | 22.6 Million | 17.69 Million | 5.96 Million | 5.54 Million |
Deferred income taxes | -9.2 Million | -705.95 Thousand | -593.3 Thousand | -686.4 Thousand | -540.6 Thousand | - |
Stock-based compensation | 20.02 Million | 2.4 Million | - | - | - | - |
Change in working capital | -79.27 Million | -141.85 Million | -132.74 Million | -47.27 Million | -20.37 Million | -21.84 Million |
Other non-cash items | 21.39 Million | 8.11 Million | 499.82 Thousand | -8.92 Million | -27.92 Million | -27.72 Million |
Investing Cash Flow | -203.27 Million | -219.48 Million | -6.41 Million | -15.92 Million | -45.69 Million | -58.53 Million |
Investments in PPE | -198.57 Million | -54.7 Million | -7.73 Million | -15.92 Million | -45.69 Million | -58.58 Million |
Acquisitions | 0.37 | 3200.00 | 1.31 Million | - | - | - |
Investment purchases | -1.77 Billion | -933 Million | - | - | - | - |
Sales/Maturities of investments | 1.76 Billion | 768.22 Million | - | - | - | - |
Other Investing Activities | 249.96 Thousand | 0.10 | 38.63 | - | - | 56 Thousand |
Financing Cash Flow | 30.3 Million | 459.63 Million | -5.76 Million | 1.7 Million | 295.8 Thousand | 76.53 Million |
Debt repayment | -148 Million | -218.5 Million | -193.5 Million | -167 Million | -167.4 Million | -180.9 Million |
Dividends payments | -25.92 Million | -85.32 Million | -7.26 Million | -24.79 Million | -15.81 Million | -8.63 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 129.23 Million | 763.46 Million | 195 Million | 193.49 Million | 183.51 Million | 266.06 Million |
Accounts receivables | -117.65 Million | -116.38 Million | -68.36 Million | -87.55 Million | -49.82 Million | -19.62 Million |
Accounts payables | 61.62 Million | 20.01 Million | 39.54 Million | 55.87 Million | 45.1 Million | - |
Inventory | -14.03 Million | -44.78 Million | -103.33 Million | -14.89 Million | -15.1 Million | -7.41 Million |
Other working capital | -9.2 Million | -705.94 Thousand | -593.33 Thousand | -686.44 Thousand | -540.59 Thousand | -14.43 Million |
Cash at beginning of period | 303.68 Million | 32.39 Million | 33.6 Million | 18.12 Million | 44.09 Million | 14.29 Million |
Cash at end of period | 297.89 Million | 303.68 Million | 32.39 Million | 33.6 Million | 18.12 Million | 44.09 Million |
Capital Expenditure | -198.57 Million | -54.7 Million | -7.73 Million | -15.92 Million | -45.69 Million | -58.58 Million |
Effect of forex changes on cash | 197.03 Thousand | 94.41 Thousand | - | -0.69 | - | - |
Net cash flow / Change in cash | -5.79 Million | 271.28 Million | -1.21 Million | 15.48 Million | -25.96 Million | 29.79 Million |
Free Cash Flow | -31.59 Million | -23.66 Million | 3.23 Million | 13.78 Million | -26.26 Million | -46.78 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 45.08 Million | 43.06 Million | 50.66 Million | 200.71 Million | 63.33 Million | 56.85 Million |
Depreciation & Amortization | - | 6.04 Million | 6.04 Million | 24.14 Million | 5.98 Million | 5.98 Million |
Deferred income taxes | - | - | - | -9.2 Million | 91.79 Million | 72.58 Million |
Stock-based compensation | - | 17.47 Million | - | 20.02 Million | 20.02 Million | -7.21 Million |
Change in working capital | - | 75.31 Million | - | -79.27 Million | -111.81 Million | -65.37 Million |
Other non-cash items | 34.32 Million | 35.96 Million | -22.18 Million | 21.39 Million | -68.27 Million | 16.18 Million |
Investing Cash Flow | -81.59 Million | 9.52 Million | -49.02 Million | -203.27 Million | -36.81 Million | -56.5 Million |
Investments in PPE | -57.52 Million | -70.47 Million | -79.06 Million | -198.57 Million | -48.47 Million | -64.43 Million |
Acquisitions | 400 Thousand | - | 38.57 Thousand | 0.37 | - | 249.96 Thousand |
Investment purchases | -305 Million | -330 Million | -340 Million | -1.77 Billion | -565 Million | -446 Million |
Sales/Maturities of investments | 280.53 Million | 410 Million | 370 Million | 1.76 Billion | 576.66 Million | 453.68 Million |
Other Investing Activities | 400 Thousand | 81.08 Million | 30.68 Million | 249.96 Thousand | 0.71 | 0.45 |
Financing Cash Flow | -45.22 Million | -108.71 Million | -29.45 Million | 30.3 Million | 128.82 Million | -6.06 Million |
Debt repayment | -14.25 Million | -30 Million | -31 Million | -148 Million | -20.5 Million | -30 Million |
Dividends payments | -590.9 Thousand | -78.71 Million | -822.95 Thousand | -25.92 Million | -700.06 Thousand | -748.93 Thousand |
Common Stock Repurchased | - | - | -59.62 Million | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -58.88 Million | -78.71 Million | -60.45 Million | 129.23 Million | 130.02 Million | 24.68 Million |
Accounts receivables | - | 44.82 Million | - | -117.65 Million | -117.65 Million | -1.09 Million |
Accounts payables | - | - | - | 61.62 Million | - | - |
Inventory | - | 13.81 Million | - | -14.03 Million | -14.03 Million | -57.06 Million |
Other working capital | - | 16.67 Million | - | -9.2 Million | 19.87 Million | -7.21 Million |
Cash at beginning of period | 221.82 Million | 247.9 Million | 297.89 Million | 303.68 Million | 204.84 Million | 190.09 Million |
Cash at end of period | 173.82 Million | 221.82 Million | 247.9 Million | 297.89 Million | 297.89 Million | 204.84 Million |
Capital Expenditure | -57.52 Million | -70.47 Million | -79.06 Million | -198.57 Million | -48.47 Million | -64.43 Million |
Effect of forex changes on cash | -66.04 Thousand | 141.53 Thousand | 6103.58 | 197.03 Thousand | -10.14 Thousand | -21.81 Thousand |
Net cash flow / Change in cash | -48 Million | -26.07 Million | -49.98 Million | -5.79 Million | 93.04 Million | 14.74 Million |
Free Cash Flow | 21.88 Million | 2.5 Million | -50.58 Million | -31.59 Million | -47.42 Million | 14.58 Million |
SLVMF
DRMA
TROX
STYRENIX
EICHERMOT
120110